Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Osong Public Health Res Perspect > Volume 2(Suppl 1); 2011 > Article
Articles From Lessons Learned After 2009 H1N1 Pandemic to TEPIK’s Preparedness and Response Plan
Woo Joo Kim
Osong Public Health and Research Perspectives 2011;2(Suppl 1):S6-S6.
DOI: https://doi.org/10.1016/j.phrp.2011.11.024
Published online: November 30, 2011
  • 1,198 Views
  • 16 Download

Chair, Transgovernmental Enterprise of Pandemic Influenza in Korea (TEPIK), Professor, Division of Infectious Diseases, Korea University College of Medicine, Seoul, Korea.

Copyright ©2012, Korea Centers for Disease Control and Prevention

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

dd class="first" id="idm140291153553552">In response to the global spread of the H1N1 influenza virus after first being detected in North America in April 2009, WHO declared the first influenza pandemic in more than four decades on June 11 of the same year. In Korea, the arrival of the 2009 H1N1 pandemic influenza triggered an integrated response that was mainly based on the 2006 Pandemic Influenza Preparedness and Response Plan. At least 270 fatal cases, 764 laboratory-thousand confirmed cases, and 3.6 million courses of antiviral agent use were reported to the end of August 2010 in this country. Even if government tried to control and mitigate the impact of pandemic by using public health and medical countermeasures, there were several issues found during the H1N1 pandemic responses. The main difficulty was the delayed and insufficient supply of pandemic vaccine. Therefore the mass vaccination campaign was begun after the peak of pandemic and its mitigation effect on the pandemic disease burden was diminished. The amount of stockpiled antiviral agents by government was not enough in the early phase of pandemic. The rapid antigen test for the H1N1 influenza showed low sensitivity, about 50%. Many infected people were seeking to be diagnosed with rRT-PCR test, which is expensive and not useful for the decision of antiviral use because of late test report. The communications among government, medical societies, general people and mass media were also not satisfactory. Lessons learned from the national response to the H1N1 pandemic made the government to launch the TEPIK in October 2010. TEPIK will incorporate those lessons into the future pandemic preparedness planning. The mission of TEPIK is to ensure the safety of the nation and people from the threat of pandemic influenza. TEPIK focuses to establish government-academic-institute-industry collaborative system with three main strategies; to expedite sharing of R&D information and preparation of national communication; to establish the preparedness and response of R&D investment strategy for usual and pandemic phase; and to secure the innovative and leading response technology against pandemic influenza. TEPIK has 34 research projects in eight research areas, which include vaccine; therapeutics; diagnostics; basic/mechanism; clinical/ policy; surveillance/epidemiology; innovative researches; and infrastructures. Research subjects in each research area will be stated in this presentation.

Figure & Data

References

    Citations

    Citations to this article as recorded by  


      PHRP : Osong Public Health and Research Perspectives